These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 935799)

  • 1. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
    Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
    N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
    Arnfred T; Pedersen L
    Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic toxicity in the rhesus monkey treated with chenodeoxycholic acid for 6 months: biochemical and ultrastructural studies.
    Dyrszka H; Salen G; Zaki FG; Chen T; Mosbach EH
    Gastroenterology; 1976 Jan; 70(1):93-104. PubMed ID: 812760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
    Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
    Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study.
    Stellaard F; Klein PD; Hofmann AF; Lachin JM
    J Lab Clin Med; 1985 Apr; 105(4):504-13. PubMed ID: 3981060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in biliary bile acid composition and cholesterol saturation of bile in patients with cholesterol gallstones following treatment with ursodeoxycholic acid].
    Stiehl A; Czygan P; Fröhling W; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():501-2. PubMed ID: 612017
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? The speed of change in biliary lipids and bile acids after starting and stopping treatment.
    Iser JH; Murphy GM; Dowling RH
    Gut; 1975 Oct; 16(10):840. PubMed ID: 1205324
    [No Abstract]   [Full Text] [Related]  

  • 20. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.